Live feed
Filing
SC 13D/A
SC 13D/A0001493152-23-043240·REVIVA PHARMACEUTICALS HOLDINGS, INC.
Schedule 13D ownership disclosure
REVIVA PHARMACEUTCLS HLDGS I
Security class unavailable · CUSIP: 76152G100
Event date: 2023-11-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,656,918
- Percent of class
- 9.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-23-043240
- Form type
- SC 13D/A
- Filer
- REVIVA PHARMACEUTICALS HOLDINGS, INC.
- CIK
- CIK 1742927
- Filed
- Nov 30, 2023
- Reporting period
- Nov 20, 2023
- Description
- Schedule 13D beneficial ownership